The Ghana Medical Trust Fund (GMTF) has begun strategic engagements with global pharmaceutical partners as it prepares to roll out direct support for patients across the country.

As part of these efforts, the Fund is engaging Novartis to ensure that Ghanaians can access quality medicines more quickly and at a lower cost.

According to the Fund, discussions with Novartis are aimed at exploring practical ways to strengthen access to essential medicines while easing the financial burden on patients.

The engagement forms part of a broader strategy to build sustainable partnerships that deliver real health outcomes for people in need.

Officials of the Ghana Medical Trust Fund met with the Novartis team on Tuesday afternoon to begin detailed conversations on the scope and structure of the proposed partnership.

The meeting focused on identifying areas of collaboration that would support patient care, improve medicine availability and enhance efficiency within the healthcare system.

The Fund noted that such engagements are critical to ensuring that support reaches patients in meaningful ways.

“Conversations like this help ensure that assistance gets to patients across Ghana in ways that truly make a difference,” the GMTF stated, emphasising the importance of collaboration between public institutions and private sector partners.

Reaffirming its mission, the Ghana Medical Trust Fund said it remains committed to compassionate, people-centred healthcare delivery.

“At the Ghana Medical Trust Fund, we care,” the statement said, adding that the initiative reflects the broader vision of providing timely, affordable and quality healthcare support to Ghanaians — a commitment the Fund describes as Mahama Cares.